July 2025
1. WANG QY, Benzerdjeb N, Jaquet S, Stepanov A, et al
   Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer.
   Hum Pathol. 2025;163:105877.
   

   >> Share

   
   June 2025
2. LIN R, Li H, Baraban E, Lotan T, et al
   Atypical intraductal proliferation (AIP) of the prostate: Findings in repeat biopsy or radical prostatectomy in patients who met pathologic criteria for active surveillance.
   Hum Pathol. 2025;160:105841.
   

   >> Share

   
   April 2024
3. WISSING M, Brimo F, McKercher G, Scarlata E, et al
   Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada.
   Hum Pathol. 2024 Apr 10:S0046-8177(24)00054.
   

   >> Share

   
   February 2024
4. MAHLOW J, Barry M, Albertson DJ, Jo YJ, et al
   Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.
   Hum Pathol. 2024;144:28-33.
   

   >> Share

   
   January 2024
5. BACHERT SE, Di J, Zhang S, Short HE, et al
   TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
   Hum Pathol. 2024;143:42-49.
   

   >> Share

   
   December 2023
6. DING Y, Bu P, Assylbekova B, Ruder S, et al
   Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death.
   Hum Pathol. 2023 Dec 28:S0046-8177(23)00258.
   

   >> Share

   
   
7. NWANZE J, Teramoto Y, Wang Y, Miyamoto H, et al
   Clinical impact of perineural invasion encircled completely vs. incompletely by prostate cancer on needle core biopsy.
   Hum Pathol. 2023;143:71-74.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share